Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-25

Clinical Trial Update: A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing safety and local anesthetic effect of AG-920 ophthalmic solution in a pediatric population; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AG-920 ophthalmic solution

Snippet

Sponsor: American Genomics, LLC | Conditions: Anesthesia, Local | Phase 3 | Status: COMPLETED | Results posted: 2023-10-25